The NF-kB Pathway as a Potential Target for Autoimmune Disease Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|23|2827-2837

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.23, 2004-09, pp. : 2827-2837

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NF-&kgr;B as a therapeutic target in autoimmune disease

By O’Sullivan Brendan   Thompson Angus   Thomas Ranjeny  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 111-122

Informa Healthcare

Access to resources Recommend Favorite

The Ubiquitin-Dependent Proteolytic System and other Potential Targets for the Modulation of Nuclear Factor-kB (NF-kB)

By  

Current Drug Targets, Vol. 1, Iss. 4, 2000-01 ,pp. : 387-399

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 9, 2014-11 ,pp. : 1615-1626

Bentham Science Publishers

Access to resources Recommend Favorite

Bangladeshi Medicinal Plant Extracts Inhibiting Molecular Interactions between Nuclear Factors and Target DNA Sequences Mimicking NF-kB Binding Sites

By  

Medicinal Chemistry, Vol. 1, Iss. 4, 2005-06 ,pp. : 327-333

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr;B as a target for cancer therapy

By Melisi Davide   Chiao Paul J  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 133-144

Informa Healthcare

Access to resources Recommend Favorite